Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
NASDAQ:TRIB
Price:
1.63 USD
-3.55%
Market Closed
Updated:
May 29, 2024
Trinity Biotech PLC
Total Receivables
|
Trinity Biotech PLC
Total Receivables Peer Comparison
Comparables:
MDT
STE
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Total Receivables
$15.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-5%
|
|
|
Medtronic PLC
NYSE:MDT
|
Total Receivables
$6.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
|
STERIS plc
NYSE:STE
|
Total Receivables
$1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
See Also
What is Trinity Biotech PLC's Total Receivables?
Total Receivables
15.4m
USD
15.4m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Total Receivables amounts to 15.4m USD.
What is Trinity Biotech PLC's Total Receivables growth rate?
Total Receivables CAGR 10Y
-5%
-5%
Over the last year, the Total Receivables growth was -12%. The average annual Total Receivables growth rates for Trinity Biotech PLC have been -16% over the past three years , -10% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
